1‐year mortality · previously treated patients with mRCC
Targeted immunotherapy alone probably leads to lower 1‐year mortality compared with standard targeted therapies (moderate certainty).
1 finding from 1 review
Quality of life: improved to an important degree · previously treated patients with mRCC
Targeted immunotherapy alone probably leads to higher quality of life: Clinically relevant improvement in FKSI‐DRS compared with standard targeted therapies (moderate certainty).
2 findings from 1 review
Adverse events (grade ≥ 3) · previously treated patients with mRCC
Targeted immunotherapy alone probably leads to lower adverse events (grade ≥ 3) compared with standard targeted therapies (moderate certainty).
1 finding from 1 review
Urologic symptom scores · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Retreatment Participants requiring additional procedures or surgery · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Transurethral microwave thermotherapy may leads to lower retreatment Participants requiring additional procedures or surgery compared with sham treatment (low certainty).
1 finding from 1 review
Erectile function · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Ejaculatory function · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Quality of life · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Major adverse events · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Transurethral microwave thermotherapy probably leads to lower major adverse events compared with transurethral resection of the prostate (moderate certainty).
1 finding from 1 review
Retreatment Participants requiring additional procedures or surgery · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Transurethral microwave thermotherapy probably leads to higher retreatment Participants requiring additional procedures or surgery compared with transurethral resection of the prostate (moderate certainty).
1 finding from 1 review
Erectile function · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Transurethral microwave thermotherapy showed no clear difference in erectile function (sexually‐active men only) compared with transurethral resection of the prostate (low certainty).
1 finding from 1 review
Ejaculatory function · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Transurethral microwave thermotherapy may leads to lower ejaculatory function (sexually‐active men only) compared with transurethral resection of the prostate (low certainty).
1 finding from 1 review
Urologic symptom scores · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Quality of life · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Major adverse events · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Time to bladder cancer recurrence (absolute effect size estimates based on recurrence rate at 12 months)
Single‐dose intravesical chemotherapy instillation may leads to lower time to bladder cancer recurrence (absolute effect size estimates… compared with placebo or observation after nephroureterectomy (low certainty).
1 finding from 1 review
Time to death from UTUC5
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events
1 finding from 1 review
Time to death from any cause5
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor adverse events
1 finding from 1 review